Resonant Capital Advisors, LLC Gilead Sciences, Inc. Transaction History
Resonant Capital Advisors, LLC
- $1.35 Billion
- Q4 2024
A detailed history of Resonant Capital Advisors, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Resonant Capital Advisors, LLC holds 17,482 shares of GILD stock, worth $1.92 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
17,482
Previous 15,041
16.23%
Holding current value
$1.92 Million
Previous $1.26 Million
28.1%
% of portfolio
0.12%
Previous 0.09%
Shares
8 transactions
Others Institutions Holding GILD
# of Institutions
2,090Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.7 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.88 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.64 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.37 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...